Home / Research library / TB-500 Fragment (17-23)
TB-500 Fragment (17-23): molecular data, studies & sources
The selected analytical study describes an acetylated thymosin beta-4 active-region fragment under the name TB-500. It concerns detection in equine samples, not a human efficacy trial. A peptide fragment and full-length thymosin beta-4 are distinct identities.
Overview sources: PMID 23084823
Compiled by PeptideTech Editors · Sources checked · Selected bibliography, not a systematic review
Molecular formula, weight & structure
Molecular record not yet resolved
A sufficiently specific molecular record was not resolved for this name. Formula, molecular weight and structure are withheld until the exact sequence, salt or preparation can be verified.
MF: not assigned · MW: not assigned · Structure: not assigned
Human and clinical studies
Selected human-study records are shown with their indexed or reviewed study type. Check the original article for the intervention, formulation and controls; the molecule can also be a comparator or measured variable.
No matching human study was retained in this selected bibliography. This is a documented evidence gap in our selection, not proof that no study exists.
Preclinical research, reviews & other publications
Animal studies, laboratory experiments, reviews and other indexed papers answer different questions. A review is secondary evidence; a case report does not estimate how often an outcome occurs.
- Preclinical / laboratory research
Doping control analysis of TB-500, a synthetic version of an active region of thymosin β₄, in equine urine and plasma by liquid chromatography-mass spectrometry.
Ho EN, Kwok WH, Lau MY et al. · Journal of chromatography. A · 2012
Analytical detection of an acetylated thymosin beta-4 fragment in horse urine and plasma. This is not a human treatment trial.
PMID 23084823 · DOI: 10.1016/j.chroma.2012.09.043
TB-500 Fragment (17-23) supplier sources
Scientific sources describe molecules and experiments. The commercial links below identify recorded supplier packages. A publication or chemical database entry does not verify the seller, purity, sterility or contents of a lot. Some links are affiliate links; see our disclosure.
Compare all TB-500 Fragment (17-23) sizes, forms and supplier prices →
| Supplier | Recorded packages | Example source listing |
|---|---|---|
| American PeptidesUSD | 10mg Vial1 recorded offers | 10mg Vial · $100.00Checked Sep 21, 2026Supplier listing |
| Amino USAUSD | 10mg Vial1 recorded offers | 10mg Vial · $36.00Checked Sep 16, 2026Supplier listing |
Reference sources & further reading
The citations above link directly to publication records. Encyclopedia links are background reading and are not used to establish clinical effectiveness.
Search for additional research
These links run searches; their results have not been individually reviewed and can include unrelated compounds.
Research information is not a dosing guide or a recommendation for personal use. Study findings are specific to the formulation, population and methods tested. Read our source and correction policy.
Related research profiles
AOD-9604
C78H123N23O23S2
1815.1 g/mol · PubChem CID 71300630
2 selected publications · 0 human study records
ARA-290
C51H84N16O21
1257.3 g/mol · PubChem CID 91810664
7 selected publications · 3 human study records
BPC-157
C62H98N16O22
1419.5 g/mol · PubChem CID 9941957
7 selected publications · 1 human study records
KPV
C16H30N4O4
342.43 g/mol · PubChem CID 125672
0 selected publications · 0 human study records
LL-37
C205H340N60O53
4493 g/mol · PubChem CID 16198951
4 selected publications · 1 human study records
TB-500
Molecular identity needs further verification
1 selected publications · 0 human study records